Published on Sunday November 05, 2023

Smooth Drug Development October 2023 News Release

We are working on the following new projects:

  • We signed a contract for medical writing activities for a phase III trial with glucosamine + chondroitin sulfate.
  • We are signing a master service agreement for medical writing, biostatistics, and data management services in post marketing programs for a top twenty companies.

We are happy to reach the following milestones in our projects:

  • We finished to enroll patients in Russia and India into an international phase III clinical trial of an original drug for patients with chronic myeloid leukemia. 180 subjects were enrolled. CTA was received in Pakistan.
  • 10 patients were randomized in a phase III clinical trial in paroxysmal nocturnal hemoglobinuria.